Oppenheimer on TransMedics Group (TMDX): 'Concerns on Jet Fuel Costs Misplaced'
Tweet Send to a Friend
Oppenheimer analyst Suraj Kalia reiterated an Outperform rating and $175.00 price target on TransMedics Group (NASDAQ: TMDX)The analyst comments "Rising ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
